

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.25232363 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 8.22911541 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 8.22911541 |
| 4 | regulation of fibrinolysis (GO:0051917) | 8.09411201 |
| 5 | drug catabolic process (GO:0042737) | 8.00933391 |
| 6 | negative regulation of fibrinolysis (GO:0051918) | 7.84087534 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 7.83628639 |
| 8 | glyoxylate metabolic process (GO:0046487) | 7.79255461 |
| 9 | complement activation, alternative pathway (GO:0006957) | 7.73382752 |
| 10 | regulation of protein activation cascade (GO:2000257) | 7.55062485 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 7.52638669 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.52638669 |
| 13 | omega-hydroxylase P450 pathway (GO:0097267) | 7.48210478 |
| 14 | regulation of complement activation (GO:0030449) | 7.09991009 |
| 15 | ethanol oxidation (GO:0006069) | 6.70757088 |
| 16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.65247896 |
| 17 | protein carboxylation (GO:0018214) | 6.65247896 |
| 18 | fibrinolysis (GO:0042730) | 6.27939379 |
| 19 | urea metabolic process (GO:0019627) | 6.22648391 |
| 20 | blood coagulation, intrinsic pathway (GO:0007597) | 6.03645106 |
| 21 | aromatic amino acid family catabolic process (GO:0009074) | 5.70301541 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 5.69755750 |
| 23 | drug metabolic process (GO:0017144) | 5.69191227 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.66604783 |
| 25 | bile acid biosynthetic process (GO:0006699) | 5.64807231 |
| 26 | negative regulation of sterol transport (GO:0032372) | 5.63829792 |
| 27 | negative regulation of cholesterol transport (GO:0032375) | 5.63829792 |
| 28 | oxidative demethylation (GO:0070989) | 5.58277360 |
| 29 | cellular glucuronidation (GO:0052695) | 5.54959966 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.47095656 |
| 31 | regulation of plasminogen activation (GO:0010755) | 5.42246507 |
| 32 | ethanol metabolic process (GO:0006067) | 5.38487091 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 5.35077667 |
| 34 | urea cycle (GO:0000050) | 5.32625866 |
| 35 | uronic acid metabolic process (GO:0006063) | 5.27574706 |
| 36 | glucuronate metabolic process (GO:0019585) | 5.27574706 |
| 37 | bile acid metabolic process (GO:0008206) | 5.08834876 |
| 38 | phenylpropanoid metabolic process (GO:0009698) | 5.03754035 |
| 39 | protein activation cascade (GO:0072376) | 4.99254191 |
| 40 | imidazole-containing compound metabolic process (GO:0052803) | 4.91114255 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.83259155 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.83259155 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.83259155 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.78347355 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.78291557 |
| 46 | acylglycerol homeostasis (GO:0055090) | 4.78291557 |
| 47 | negative regulation of blood coagulation (GO:0030195) | 4.76263313 |
| 48 | negative regulation of hemostasis (GO:1900047) | 4.76263313 |
| 49 | glycine metabolic process (GO:0006544) | 4.75375051 |
| 50 | high-density lipoprotein particle remodeling (GO:0034375) | 4.74514584 |
| 51 | phospholipid efflux (GO:0033700) | 4.71654918 |
| 52 | regulation of cholesterol esterification (GO:0010872) | 4.63016935 |
| 53 | complement activation (GO:0006956) | 4.60974223 |
| 54 | negative regulation of protein activation cascade (GO:2000258) | 4.57834948 |
| 55 | complement activation, classical pathway (GO:0006958) | 4.56468825 |
| 56 | S-adenosylmethionine metabolic process (GO:0046500) | 4.54241604 |
| 57 | cholesterol efflux (GO:0033344) | 4.53349819 |
| 58 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.51092649 |
| 59 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.51092649 |
| 60 | acute-phase response (GO:0006953) | 4.49765078 |
| 61 | regulation of humoral immune response (GO:0002920) | 4.44372653 |
| 62 | bile acid and bile salt transport (GO:0015721) | 4.42931340 |
| 63 | glutamate metabolic process (GO:0006536) | 4.36625845 |
| 64 | negative regulation of coagulation (GO:0050819) | 4.32552268 |
| 65 | negative regulation of wound healing (GO:0061045) | 4.26685624 |
| 66 | alkaloid metabolic process (GO:0009820) | 4.25817923 |
| 67 | negative regulation of lipase activity (GO:0060192) | 4.19682075 |
| 68 | reverse cholesterol transport (GO:0043691) | 4.18704801 |
| 69 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.17558820 |
| 70 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.15737143 |
| 71 | amino-acid betaine metabolic process (GO:0006577) | 4.12000049 |
| 72 | positive regulation of blood coagulation (GO:0030194) | 4.10795107 |
| 73 | positive regulation of hemostasis (GO:1900048) | 4.10795107 |
| 74 | intestinal cholesterol absorption (GO:0030299) | 4.04332092 |
| 75 | alpha-amino acid catabolic process (GO:1901606) | 4.01129674 |
| 76 | opsonization (GO:0008228) | 4.00238167 |
| 77 | cytolysis (GO:0019835) | 3.87658884 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 3.84435968 |
| 79 | positive regulation of coagulation (GO:0050820) | 3.78046575 |
| 80 | plasma lipoprotein particle clearance (GO:0034381) | 3.76617097 |
| 81 | response to mercury ion (GO:0046689) | 3.76213618 |
| 82 | flavonoid metabolic process (GO:0009812) | 3.74987848 |
| 83 | negative regulation of complement activation (GO:0045916) | 3.73632256 |
| 84 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.73188161 |
| 85 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.73188161 |
| 86 | aromatic amino acid family metabolic process (GO:0009072) | 3.69991444 |
| 87 | arginine metabolic process (GO:0006525) | 3.69541938 |
| 88 | cellular ketone body metabolic process (GO:0046950) | 3.68824818 |
| 89 | plasma lipoprotein particle assembly (GO:0034377) | 3.68650418 |
| 90 | plasma lipoprotein particle organization (GO:0071827) | 3.67886505 |
| 91 | heme transport (GO:0015886) | 3.65217679 |
| 92 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.61322870 |
| 93 | regulation of apoptotic cell clearance (GO:2000425) | 3.49626691 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.46271676 |
| 95 | tryptophan catabolic process (GO:0006569) | 3.45759319 |
| 96 | indole-containing compound catabolic process (GO:0042436) | 3.45759319 |
| 97 | indolalkylamine catabolic process (GO:0046218) | 3.45759319 |
| 98 | protein-lipid complex subunit organization (GO:0071825) | 3.45565333 |
| 99 | cellular amino acid catabolic process (GO:0009063) | 3.45355489 |
| 100 | hormone catabolic process (GO:0042447) | 3.43323423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.84663417 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.54613180 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.76532146 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.57267615 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.21482489 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.58681176 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.51247949 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.04415618 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98516861 |
| 10 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.40400717 |
| 11 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.26335454 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.19631995 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.11086638 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3565292 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.96169926 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.77636815 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.63178754 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60973790 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30403166 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23636668 |
| 21 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.22483652 |
| 22 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21684611 |
| 23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18953488 |
| 24 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16918758 |
| 25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.07519198 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.01268790 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00709176 |
| 28 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98811193 |
| 29 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93204287 |
| 30 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.91789466 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90391907 |
| 32 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85268567 |
| 33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85233379 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83622370 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.82638749 |
| 36 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78748834 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78361557 |
| 38 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77904351 |
| 39 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77034276 |
| 40 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76974951 |
| 41 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.76703226 |
| 42 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75607387 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.75051975 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.74622908 |
| 45 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.74219956 |
| 46 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.73561776 |
| 47 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73554436 |
| 48 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.73250394 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.73228020 |
| 50 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.67428230 |
| 51 | CBP_21632823_ChIP-Seq_H3396_Human | 0.67253187 |
| 52 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.66663797 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.66272017 |
| 54 | AR_20517297_ChIP-Seq_VCAP_Human | 0.66117880 |
| 55 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.65520775 |
| 56 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.64514444 |
| 57 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64478361 |
| 58 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.63448201 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.63318777 |
| 60 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.63185765 |
| 61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.62280749 |
| 62 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.61632724 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.61504832 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 0.61223181 |
| 65 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.61166812 |
| 66 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.60202147 |
| 67 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.59847378 |
| 68 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.59749003 |
| 69 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59302608 |
| 70 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.58893786 |
| 71 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58387819 |
| 72 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58085222 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.57690179 |
| 74 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.57546707 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.57374121 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.57007882 |
| 77 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.55960414 |
| 78 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.55771648 |
| 79 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.55524784 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.55166224 |
| 81 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.54697483 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.54226326 |
| 83 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.52753939 |
| 84 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.52503351 |
| 85 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.52385597 |
| 86 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.52165512 |
| 87 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.51938190 |
| 88 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.51183643 |
| 89 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.51143057 |
| 90 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.50911082 |
| 91 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.50855866 |
| 92 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.50571092 |
| 93 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.50487949 |
| 94 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50323720 |
| 95 | NFYA_21822215_ChIP-Seq_K562_Human | 0.50201836 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.49854205 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.49666045 |
| 98 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.49315943 |
| 99 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.49133829 |
| 100 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.48701966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.50636299 |
| 2 | MP0005360_urolithiasis | 6.28114896 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.26556751 |
| 4 | MP0005365_abnormal_bile_salt | 5.87864908 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.59140487 |
| 6 | MP0003195_calcinosis | 5.10343208 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.01088371 |
| 8 | MP0003252_abnormal_bile_duct | 3.82894751 |
| 9 | MP0003868_abnormal_feces_composition | 3.35920692 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.35069655 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.07681045 |
| 12 | MP0009697_abnormal_copulation | 2.57593621 |
| 13 | MP0009840_abnormal_foam_cell | 2.57568302 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.42504054 |
| 15 | MP0005332_abnormal_amino_acid | 2.40350847 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.11070133 |
| 17 | MP0002876_abnormal_thyroid_physiology | 1.97365722 |
| 18 | MP0000609_abnormal_liver_physiology | 1.84371972 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.78394656 |
| 20 | MP0005670_abnormal_white_adipose | 1.76082094 |
| 21 | MP0010368_abnormal_lymphatic_system | 1.67410677 |
| 22 | MP0001764_abnormal_homeostasis | 1.52789708 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.27385959 |
| 24 | MP0001661_extended_life_span | 1.23967585 |
| 25 | MP0005408_hypopigmentation | 1.22082587 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.14490489 |
| 27 | MP0005451_abnormal_body_composition | 1.13775073 |
| 28 | MP0002132_abnormal_respiratory_system | 1.06471822 |
| 29 | MP0000598_abnormal_liver_morphology | 1.03304445 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.01080525 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99118608 |
| 32 | MP0009643_abnormal_urine_homeostasis | 0.97036283 |
| 33 | MP0000604_amyloidosis | 0.95558678 |
| 34 | MP0003879_abnormal_hair_cell | 0.93170937 |
| 35 | MP0001915_intracranial_hemorrhage | 0.92924967 |
| 36 | MP0009642_abnormal_blood_homeostasis | 0.86368974 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 0.85321327 |
| 38 | MP0002971_abnormal_brown_adipose | 0.84972133 |
| 39 | MP0009763_increased_sensitivity_to | 0.82985282 |
| 40 | MP0009053_abnormal_anal_canal | 0.80951942 |
| 41 | MP0005376_homeostasis/metabolism_phenot | 0.80017444 |
| 42 | MP0003186_abnormal_redox_activity | 0.77943124 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 0.77777271 |
| 44 | MP0009764_decreased_sensitivity_to | 0.72783009 |
| 45 | MP0008469_abnormal_protein_level | 0.71663038 |
| 46 | MP0005395_other_phenotype | 0.70873011 |
| 47 | MP0003690_abnormal_glial_cell | 0.70091929 |
| 48 | MP0005187_abnormal_penis_morphology | 0.68927063 |
| 49 | MP0002168_other_aberrant_phenotype | 0.68527906 |
| 50 | MP0005464_abnormal_platelet_physiology | 0.67977859 |
| 51 | MP0004130_abnormal_muscle_cell | 0.63785090 |
| 52 | MP0005535_abnormal_body_temperature | 0.63236473 |
| 53 | MP0008872_abnormal_physiological_respon | 0.62026442 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 0.61301373 |
| 55 | MP0005330_cardiomyopathy | 0.60598357 |
| 56 | MP0002282_abnormal_trachea_morphology | 0.56774737 |
| 57 | MP0005266_abnormal_metabolism | 0.56632956 |
| 58 | MP0008874_decreased_physiological_sensi | 0.56612471 |
| 59 | MP0003011_delayed_dark_adaptation | 0.55126361 |
| 60 | MP0005334_abnormal_fat_pad | 0.52769808 |
| 61 | MP0005058_abnormal_lysosome_morphology | 0.52107468 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 0.51727899 |
| 63 | MP0003638_abnormal_response/metabolism_ | 0.48136210 |
| 64 | MP0002249_abnormal_larynx_morphology | 0.45933428 |
| 65 | MP0000249_abnormal_blood_vessel | 0.43612908 |
| 66 | MP0001986_abnormal_taste_sensitivity | 0.41379701 |
| 67 | MP0005023_abnormal_wound_healing | 0.40002321 |
| 68 | MP0003646_muscle_fatigue | 0.39144872 |
| 69 | MP0003075_altered_response_to | 0.37746429 |
| 70 | MP0000566_synostosis | 0.36956732 |
| 71 | MP0005448_abnormal_energy_balance | 0.36598102 |
| 72 | MP0004883_abnormal_blood_vessel | 0.34982437 |
| 73 | MP0005164_abnormal_response_to | 0.34626150 |
| 74 | MP0009115_abnormal_fat_cell | 0.34522341 |
| 75 | MP0002089_abnormal_postnatal_growth/wei | 0.33887931 |
| 76 | MP0003329_amyloid_beta_deposits | 0.33276419 |
| 77 | MP0002269_muscular_atrophy | 0.33238102 |
| 78 | MP0002332_abnormal_exercise_endurance | 0.32289422 |
| 79 | MP0003953_abnormal_hormone_level | 0.32247731 |
| 80 | MP0005166_decreased_susceptibility_to | 0.31783079 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.30554022 |
| 82 | MP0000920_abnormal_myelination | 0.28888977 |
| 83 | MP0002090_abnormal_vision | 0.28629415 |
| 84 | MP0005666_abnormal_adipose_tissue | 0.28513502 |
| 85 | MP0002136_abnormal_kidney_physiology | 0.28393896 |
| 86 | MP0005385_cardiovascular_system_phenoty | 0.28210143 |
| 87 | MP0001544_abnormal_cardiovascular_syste | 0.28210143 |
| 88 | MP0009785_altered_susceptibility_to | 0.27791134 |
| 89 | MP0000751_myopathy | 0.26952904 |
| 90 | MP0000639_abnormal_adrenal_gland | 0.26609012 |
| 91 | MP0002128_abnormal_blood_circulation | 0.25939955 |
| 92 | MP0010630_abnormal_cardiac_muscle | 0.24644899 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.24417332 |
| 94 | MP0000467_abnormal_esophagus_morphology | 0.23670508 |
| 95 | MP0004215_abnormal_myocardial_fiber | 0.23276636 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 0.22634855 |
| 97 | MP0004036_abnormal_muscle_relaxation | 0.22511805 |
| 98 | MP0004272_abnormal_basement_membrane | 0.22011558 |
| 99 | MP0006138_congestive_heart_failure | 0.21964452 |
| 100 | MP0003632_abnormal_nervous_system | 0.21883839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.92189338 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 9.00879490 |
| 3 | Complement deficiency (HP:0004431) | 9.00841502 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.68716364 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 7.94905199 |
| 6 | Abnormality of complement system (HP:0005339) | 7.20281605 |
| 7 | Joint hemorrhage (HP:0005261) | 6.51638787 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 6.03115607 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.94507157 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 5.78202551 |
| 11 | Glomerulonephritis (HP:0000099) | 5.24659909 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 5.08797501 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.96098047 |
| 14 | Xanthomatosis (HP:0000991) | 4.90243010 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.81461191 |
| 16 | Spontaneous abortion (HP:0005268) | 4.67079617 |
| 17 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.27617557 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.16107452 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.14554930 |
| 20 | Abnormality of the intrinsic pathway (HP:0010989) | 3.80428900 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 3.73373056 |
| 22 | Nephritis (HP:0000123) | 3.65470728 |
| 23 | Fat malabsorption (HP:0002630) | 3.34574224 |
| 24 | Hyperglycinemia (HP:0002154) | 3.29628646 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 3.28798496 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.28309466 |
| 27 | Gingival bleeding (HP:0000225) | 3.20382361 |
| 28 | Hyperammonemia (HP:0001987) | 3.18212441 |
| 29 | Hypercholesterolemia (HP:0003124) | 3.09158769 |
| 30 | Epidermoid cyst (HP:0200040) | 3.02966719 |
| 31 | Hemorrhage of the eye (HP:0011885) | 2.96770814 |
| 32 | Delayed CNS myelination (HP:0002188) | 2.91336545 |
| 33 | Generalized aminoaciduria (HP:0002909) | 2.89620643 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.83464791 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 2.83464791 |
| 36 | Mitral stenosis (HP:0001718) | 2.77325129 |
| 37 | Vascular calcification (HP:0004934) | 2.74174784 |
| 38 | Thrombophlebitis (HP:0004418) | 2.73074068 |
| 39 | Menorrhagia (HP:0000132) | 2.70627121 |
| 40 | Purpura (HP:0000979) | 2.69658778 |
| 41 | Steatorrhea (HP:0002570) | 2.55686957 |
| 42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.55015071 |
| 43 | Rickets (HP:0002748) | 2.54622572 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 2.53635619 |
| 45 | Hyperglycinuria (HP:0003108) | 2.49930572 |
| 46 | Osteomalacia (HP:0002749) | 2.47826212 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 2.46755702 |
| 48 | Cardiovascular calcification (HP:0011915) | 2.40828059 |
| 49 | Fair hair (HP:0002286) | 2.40618582 |
| 50 | Pulmonary embolism (HP:0002204) | 2.37308920 |
| 51 | Neonatal hypoglycemia (HP:0001998) | 2.36045446 |
| 52 | Hyperbilirubinemia (HP:0002904) | 2.33814005 |
| 53 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.32848415 |
| 54 | Hepatocellular carcinoma (HP:0001402) | 2.29580897 |
| 55 | Atrioventricular block (HP:0001678) | 2.17030335 |
| 56 | Reduced antithrombin III activity (HP:0001976) | 2.16257789 |
| 57 | Metabolic acidosis (HP:0001942) | 2.14336518 |
| 58 | Abnormal gallbladder physiology (HP:0012438) | 2.12828937 |
| 59 | Cholecystitis (HP:0001082) | 2.12828937 |
| 60 | Cholelithiasis (HP:0001081) | 2.05956793 |
| 61 | Myocardial infarction (HP:0001658) | 2.04144832 |
| 62 | Arthropathy (HP:0003040) | 2.03582470 |
| 63 | Deep venous thrombosis (HP:0002625) | 10.2577306 |
| 64 | Skin nodule (HP:0200036) | 1.98733421 |
| 65 | Abnormality of the Achilles tendon (HP:0005109) | 1.97653489 |
| 66 | Abnormal gallbladder morphology (HP:0012437) | 1.96097921 |
| 67 | Poikilocytosis (HP:0004447) | 1.96085713 |
| 68 | Ketosis (HP:0001946) | 1.95324808 |
| 69 | Abnormality of urine glucose concentration (HP:0011016) | 1.94021937 |
| 70 | Glycosuria (HP:0003076) | 1.94021937 |
| 71 | Hyperphosphaturia (HP:0003109) | 1.91473073 |
| 72 | Increased serum pyruvate (HP:0003542) | 1.88405840 |
| 73 | Joint swelling (HP:0001386) | 1.87575154 |
| 74 | Abnormality of vitamin metabolism (HP:0100508) | 1.83736539 |
| 75 | Gangrene (HP:0100758) | 1.80310532 |
| 76 | Acanthocytosis (HP:0001927) | 1.77770623 |
| 77 | Elevated alkaline phosphatase (HP:0003155) | 1.77091089 |
| 78 | Hypophosphatemic rickets (HP:0004912) | 1.75851084 |
| 79 | Epistaxis (HP:0000421) | 1.75495277 |
| 80 | Irritability (HP:0000737) | 1.74734498 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 1.71897701 |
| 82 | Amyloidosis (HP:0011034) | 1.70449469 |
| 83 | Increased serum ferritin (HP:0003281) | 1.67579000 |
| 84 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.66189837 |
| 85 | Hypoglycemic coma (HP:0001325) | 1.64606501 |
| 86 | Enlarged kidneys (HP:0000105) | 1.63968493 |
| 87 | Abnormality of purine metabolism (HP:0004352) | 1.63860685 |
| 88 | Abnormality of glycolysis (HP:0004366) | 1.63456091 |
| 89 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.62496533 |
| 90 | Bifid scrotum (HP:0000048) | 1.61997527 |
| 91 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.60244756 |
| 92 | Generalized hypopigmentation of hair (HP:0011358) | 1.59516064 |
| 93 | Retinal atrophy (HP:0001105) | 1.56201505 |
| 94 | Increased mean platelet volume (HP:0011877) | 1.55529973 |
| 95 | Abnormal urine phosphate concentration (HP:0012599) | 1.55065350 |
| 96 | Heart block (HP:0012722) | 1.52370097 |
| 97 | Gout (HP:0001997) | 1.52334315 |
| 98 | Reticulocytosis (HP:0001923) | 1.50950117 |
| 99 | Blue irides (HP:0000635) | 1.50905188 |
| 100 | Abnormal delivery (HP:0001787) | 1.50274453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 4.79915918 |
| 2 | ERN1 | 4.07413189 |
| 3 | PDK2 | 3.42712584 |
| 4 | MYLK | 3.09910063 |
| 5 | RIPK1 | 2.91923046 |
| 6 | LATS1 | 2.89736522 |
| 7 | PIK3CA | 2.81204373 |
| 8 | PIK3CG | 2.61585555 |
| 9 | TRIB3 | 2.37233099 |
| 10 | FGFR3 | 2.35616535 |
| 11 | PRKAA2 | 2.09725444 |
| 12 | BCKDK | 2.05864227 |
| 13 | PRKACG | 1.95956792 |
| 14 | NTRK3 | 1.89991652 |
| 15 | LATS2 | 1.76602750 |
| 16 | NEK9 | 1.73432849 |
| 17 | PDPK1 | 1.72548914 |
| 18 | SIK1 | 1.70110158 |
| 19 | STK38L | 1.60468989 |
| 20 | ICK | 1.55879396 |
| 21 | TYK2 | 1.51158751 |
| 22 | MAPK11 | 1.44557338 |
| 23 | EPHA3 | 1.31406404 |
| 24 | MUSK | 1.28912484 |
| 25 | PINK1 | 1.27725087 |
| 26 | MAP3K3 | 1.27127436 |
| 27 | PRKCG | 1.22977501 |
| 28 | NLK | 1.21953362 |
| 29 | STK38 | 1.19788247 |
| 30 | EPHA4 | 1.18959036 |
| 31 | AKT3 | 1.16771931 |
| 32 | TGFBR2 | 1.15139810 |
| 33 | PAK3 | 1.14232473 |
| 34 | TTN | 1.12644443 |
| 35 | MAP2K4 | 1.09879808 |
| 36 | PDK1 | 1.05070096 |
| 37 | OBSCN | 1.04986403 |
| 38 | ERBB2 | 1.02608752 |
| 39 | MAP3K2 | 1.02140844 |
| 40 | RET | 0.99044936 |
| 41 | PRKAA1 | 0.97524789 |
| 42 | PRKG1 | 0.97293706 |
| 43 | IGF1R | 0.94364907 |
| 44 | PKN2 | 0.93775727 |
| 45 | TAOK3 | 0.92146582 |
| 46 | PRKACA | 0.87728837 |
| 47 | PDGFRA | 0.83887344 |
| 48 | TNK2 | 0.83629724 |
| 49 | KSR2 | 0.83284638 |
| 50 | PRKD1 | 0.81045726 |
| 51 | PRPF4B | 0.80121324 |
| 52 | LMTK2 | 0.79561364 |
| 53 | ABL2 | 0.77969622 |
| 54 | JAK1 | 0.77578110 |
| 55 | IRAK3 | 0.77003841 |
| 56 | MAPKAPK3 | 0.76931650 |
| 57 | MAPK12 | 0.76672783 |
| 58 | MAP3K6 | 0.73391916 |
| 59 | PRKCZ | 0.71834271 |
| 60 | FER | 0.67422009 |
| 61 | SGK1 | 0.67163665 |
| 62 | MAP3K1 | 0.66920081 |
| 63 | MAP3K5 | 0.66209766 |
| 64 | SGK223 | 0.65707914 |
| 65 | SGK494 | 0.65707914 |
| 66 | WNK4 | 0.65626873 |
| 67 | CAMK2D | 0.65526454 |
| 68 | CSNK1D | 0.63980743 |
| 69 | RPS6KA3 | 0.62399195 |
| 70 | TBK1 | 0.61067359 |
| 71 | FGFR2 | 0.59178768 |
| 72 | MAPK7 | 0.59075850 |
| 73 | PRKACB | 0.58704523 |
| 74 | SGK2 | 0.57617052 |
| 75 | JAK2 | 0.55760469 |
| 76 | CSNK1E | 0.55720202 |
| 77 | SGK3 | 0.55436990 |
| 78 | NEK1 | 0.54904819 |
| 79 | MST1R | 0.52747778 |
| 80 | DMPK | 0.52287596 |
| 81 | PRKCB | 0.51468002 |
| 82 | PRKCE | 0.50960153 |
| 83 | DYRK1B | 0.50519131 |
| 84 | MAP3K7 | 0.46906409 |
| 85 | CAMK2G | 0.46580716 |
| 86 | PRKCA | 0.43826810 |
| 87 | TIE1 | 0.43651809 |
| 88 | CSF1R | 0.43376431 |
| 89 | MAP3K11 | 0.43221312 |
| 90 | FGFR1 | 0.42352628 |
| 91 | MAP2K2 | 0.41346337 |
| 92 | SRC | 0.40057191 |
| 93 | EPHB1 | 0.39904746 |
| 94 | CDC42BPA | 0.39405055 |
| 95 | MAPK4 | 0.38367929 |
| 96 | CAMK4 | 0.37641781 |
| 97 | ZAP70 | 0.37014556 |
| 98 | AKT2 | 0.36740379 |
| 99 | INSRR | 0.36308279 |
| 100 | GSK3A | 0.33379743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.70205428 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.02472685 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.95545865 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.88854988 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.25272941 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24793826 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 3.13493524 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.82381193 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.76384269 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.69763324 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.65771738 |
| 12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.60689777 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56524606 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.50408464 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.44065441 |
| 16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.36240689 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.26469945 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.19866877 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00290009 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.95009241 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.77613744 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.77478156 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.65046060 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.64044601 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.58005020 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.56766576 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55595201 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50728593 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43085107 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33949873 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31584345 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.29127560 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26678896 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24591953 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.24261853 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20100607 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20046111 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18329058 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17613338 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 1.12356976 |
| 41 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.05921399 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05188986 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01266165 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98645957 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98050291 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.97342177 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 0.96426894 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94397769 |
| 49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.90419964 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89381510 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84387179 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84339993 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.76018038 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61409040 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57839747 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.53672326 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.51116537 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48750803 |
| 59 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42607514 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38193799 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32189258 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31179757 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27992112 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.26640839 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.26114044 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23778691 |
| 67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20923552 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20834731 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20137090 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.18415818 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.17219069 |
| 72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.15149889 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13596394 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.13117574 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12079230 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.08809206 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.06953845 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.05271259 |
| 79 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02382278 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.00550540 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.00455167 |
| 82 | GABAergic synapse_Homo sapiens_hsa04727 | -0.2517397 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2500249 |
| 84 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.2500224 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2340915 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1936196 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1919326 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1780933 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1349567 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1209282 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1165681 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1129990 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1050612 |
| 94 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0879041 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0611316 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | -0.0566436 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0504488 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0443856 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0318211 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0124335 |

